ADC Therapeutics(ADCT)
$1.37+0.02 (+1.48%)
ADCT
ADC Therapeutics earnings date
$1.37
At close:+0.02 (+1.48%)
Want to see ADCT full AI Analyst Report?
ADC Therapeutics (ADCT) Q4 2022 Earnings Report
441 Followers
ADCT Q4 2022 EPS Results
- Actual EPS
- -$0.30
- Consensus EPS
- -$0.48
- Beat/Miss
- Beat by +$0.18
- One Year Ago EPS
- -$0.45
ADCT Q4 2022 Revenue Results
- Actual Revenue
- $69.80M
- Expected Revenue
- $39.38M
- Beat/Miss
- Beat by +$30.41M
- YoY Revenue Growth
- +310.34%
Earnings Announcement Details
- Quarter
- Q4 2022
- Date
- 02/28/2023
- Time
- Before Open
- Conference Call
- Tuesday, February 28, 2023
ADCT Upcoming Earnings
ADC Therapeutics's next earnings date is estimated for March 17, 2027, based on past reporting schedules.
Q4 2022 Earnings Call Audio
ADCT Q4 2022 Earnings Call
0:00 / 0:00
Q4 2022 Earnings Slide Deck
Q4 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
ADCT Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 17, 2027 | 2026 (Q4) | -0.17- | -0.04 | ― | ― |
| Nov 09, 2026 | 2026 (Q3) | -0.21-0.16 | -0.3 | 46.67% (+0.14) | |
| Aug 13, 2026 | 2026 (Q2) | -0.22-0.11 | -0.5 | 78.00% (+0.39) | |
| May 04, 2026 | 2026 (Q1) | -0.20-0.21 | -0.36 | 41.67% (+0.15) | |
| Mar 10, 2026 | 2025 (Q4) | -0.27-0.04 | -0.29 | 86.21% (+0.25) | |
| Nov 10, 2025 | 2025 (Q3) | -0.36-0.30 | -0.42 | 28.57% (+0.12) | |
| Aug 12, 2025 | 2025 (Q2) | -0.49-0.50 | -0.38 | -31.58% (-0.12) | |
| May 14, 2025 | 2025 (Q1) | -0.40-0.36 | -0.56 | 35.71% (+0.20) | |
| Mar 27, 2025 | 2024 (Q4) | -0.41-0.29 | -1.03 | 71.84% (+0.74) | |
| Nov 07, 2024 | 2024 (Q3) | -0.40-0.42 | -0.58 | 27.59% (+0.16) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


